BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally

NCT04190303 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2233

Last updated 2025-03-03

No results posted yet for this study

Summary

Background: Patients with suspected brain infections pose major challenges to low and middle income countries, including their disproportionately high burden, diverse causes with inadequate surveillance, requirement for invasive and expensive tests, and the difficulty of management without a clear diagnosis. This is all compounded by resource and system constraints. Few studies have attempted to improve the care of these people in resource-limited settings.

Aim: This study sets out to improve the diagnosis and early management of people with suspected acute (\<28 days of symptoms) brain infections in low and middle income countries, using a coordinated thematic approach.

Outcomes: The primary outcome will be proportion of people with suspected acute brain infection receiving a diagnosis. Secondary outcomes will include mortality, length of stay in hospital, quality of life, degree of disability, and proportion having a lumbar puncture test.

Participants: Children and adults with features consistent with an acute brain infection, including meningitis and encephalitis, will be recruited at a variety of hospitals in Brazil, India and Malawi.

Study procedures: An assessment of current practice and capabilities at each hospital, including patient and sample journey observations and interviews with healthcare staff, will identify barriers to optimal care. Using this, a sustainable pragmatic multi-component intervention will be produced, with components modifiable to each hospital's needs. Outcomes will be reassessed post-intervention.

Conditions

Interventions

OTHER

Pragmatic, multi-component package

This system-level intervention will be tailored to the needs and capacity of each hospital site, co-developed with policymakers and hospital staff

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV
  • Christian Medical College, Vellore, India

    collaborator OTHER
  • National Institute of Mental Health and Neuro Sciences, India

    collaborator OTHER
  • Oswaldo Cruz Foundation

    collaborator OTHER
  • Malawi-Liverpool-Wellcome Trust Clinical Research Programme

    collaborator OTHER
  • Kamuzu University of Health Sciences

    collaborator OTHER
  • University of Warwick

    collaborator OTHER
  • Liverpool School of Tropical Medicine

    collaborator OTHER
  • University of Liverpool

    lead OTHER

Principal Investigators

  • Tom Solomon, PhD · Institute of Infection & Global Health, University of Liverpool

Eligibility

Min Age
4 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-17
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Brazil
  • India
  • Malawi

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04190303 on ClinicalTrials.gov